Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT Trial
NCT00950079Phase 4Unknown
- Sponsor
- Cardiovascular Research Foundation
- Start
- Feb 2008
- Primary completion
- Aug 2009
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Phase 4, randomised trial of sodium bicarbonate ringer's solution in contrast-induced nephropathy (CIN) (2 arms), sponsored by Cardiovascular Research Foundation. Primary endpoint: Incidence of contrast-induced nephropathy at 48 hours. Status: unknown.
02
Drugs
sodium bicarbonate ringer's solution
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT00950079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950079.